Table 1 Clinical parameters of subjects

From: MiR-21-3p inhibitor exerts myocardial protective effects by altering macrophage polarization state and reducing excessive mitophagy

 

CHF (n = 12)

Normal (n = 12)

P value

Age (years)

69 ± 6.61

68 ± 3.05

0.910

Sex (male/female)

7/5

6/6

 

 BMI (kg m−2)

28.9 ± 1.17

28.94 ± 1.09

0.912

Smoking

  

0.689

 Never

4

5

 

 Past

7

5

 

 Current

2

2

 

CRP (mg L−1)

11.4 ± 1.29

4.32 ± 0.63

<0.001

NT-proBNP (pg mL−1)

6993.5 ± 813.12

98.86 ± 27.04

<0.001

NYHA class

 I

1

  

 II

2

  

 III

4

  

 IV

5

  
  1. The unpaired t-test was used between the two groups conforming to the normal distribution. P < 0.05 was considered statistically significant.
  2. CHF chronic heart failure, BMI body mass index, NYHA New York Heart Association, CRP cAMP receptor protein, NT-proBNP N-terminal pro-B type natriuretic peptide.
Back to article page